Matches in Wikidata for { <http://www.wikidata.org/entity/Q43212287> ?p ?o ?g. }
- Q43212287 description "2009 nî lūn-bûn" @default.
- Q43212287 description "2009年の論文" @default.
- Q43212287 description "2009年学术文章" @default.
- Q43212287 description "2009年学术文章" @default.
- Q43212287 description "2009年学术文章" @default.
- Q43212287 description "2009年学术文章" @default.
- Q43212287 description "2009年学术文章" @default.
- Q43212287 description "2009年学术文章" @default.
- Q43212287 description "2009年學術文章" @default.
- Q43212287 description "2009年學術文章" @default.
- Q43212287 description "2009年學術文章" @default.
- Q43212287 description "2009年學術文章" @default.
- Q43212287 description "2009年學術文章" @default.
- Q43212287 description "2009년 논문" @default.
- Q43212287 description "article científic" @default.
- Q43212287 description "article scientific" @default.
- Q43212287 description "article scientifique" @default.
- Q43212287 description "articol științific" @default.
- Q43212287 description "articolo scientifico" @default.
- Q43212287 description "artigo científico" @default.
- Q43212287 description "artigo científico" @default.
- Q43212287 description "artigo científico" @default.
- Q43212287 description "artikel ilmiah" @default.
- Q43212287 description "artikull shkencor" @default.
- Q43212287 description "artikulong pang-agham" @default.
- Q43212287 description "artykuł naukowy" @default.
- Q43212287 description "artículo científico publicado en 2009" @default.
- Q43212287 description "artículu científicu espublizáu en 2009" @default.
- Q43212287 description "bilimsel makale" @default.
- Q43212287 description "bài báo khoa học" @default.
- Q43212287 description "naučni članak" @default.
- Q43212287 description "scienca artikolo" @default.
- Q43212287 description "scientific article published on 21 December 2009" @default.
- Q43212287 description "scientific article published on 21 December 2009" @default.
- Q43212287 description "scientific article published on 21 December 2009" @default.
- Q43212287 description "teaduslik artikkel" @default.
- Q43212287 description "tieteellinen artikkeli" @default.
- Q43212287 description "tudományos cikk" @default.
- Q43212287 description "vedecký článok" @default.
- Q43212287 description "vetenskaplig artikel" @default.
- Q43212287 description "videnskabelig artikel" @default.
- Q43212287 description "vitenskapelig artikkel" @default.
- Q43212287 description "vitskapeleg artikkel" @default.
- Q43212287 description "vědecký článek" @default.
- Q43212287 description "wetenschappelijk artikel" @default.
- Q43212287 description "wissenschaftlicher Artikel" @default.
- Q43212287 description "επιστημονικό άρθρο" @default.
- Q43212287 description "мақолаи илмӣ" @default.
- Q43212287 description "наукова стаття, опублікована в грудні 2009" @default.
- Q43212287 description "научна статия" @default.
- Q43212287 description "научная статья" @default.
- Q43212287 description "научни чланак" @default.
- Q43212287 description "научни чланак" @default.
- Q43212287 description "מאמר מדעי" @default.
- Q43212287 description "مقالة علمية نشرت في 21 ديسمبر 2009" @default.
- Q43212287 description "২১ ডিসেম্বর ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43212287 description "บทความทางวิทยาศาสตร์" @default.
- Q43212287 description "სამეცნიერო სტატია" @default.
- Q43212287 name "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial" @default.
- Q43212287 name "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial" @default.
- Q43212287 type Item @default.
- Q43212287 label "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial" @default.
- Q43212287 label "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial" @default.
- Q43212287 prefLabel "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial" @default.
- Q43212287 prefLabel "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial" @default.
- Q43212287 P1433 Q43212287-45447DBA-F836-4EA3-A2B4-E5A68F4472F4 @default.
- Q43212287 P1476 Q43212287-3B059019-D607-4092-8B5D-8B51CC7AD230 @default.
- Q43212287 P2093 Q43212287-0C88CA33-0291-4444-A740-19BD7146E328 @default.
- Q43212287 P2093 Q43212287-32D1B761-1F3F-45C7-93C7-3483D5C1F74A @default.
- Q43212287 P2093 Q43212287-50B8FC77-70A6-4221-B10D-422896A1FF6D @default.
- Q43212287 P2093 Q43212287-5771C61A-4760-44DD-8659-81221E68E85C @default.
- Q43212287 P2093 Q43212287-7090A86F-0FAF-466E-A203-589F4907848D @default.
- Q43212287 P2093 Q43212287-8D8F0067-FFDA-4D8F-AD9C-CC72FE6F7F08 @default.
- Q43212287 P2093 Q43212287-923CA1FB-B84D-4EB2-BCA6-5F84493DCAB5 @default.
- Q43212287 P2093 Q43212287-982AD0B2-C451-454E-AEF0-99EDC15AA108 @default.
- Q43212287 P2093 Q43212287-A5594F52-31BC-40C4-923F-86FFC94C6B47 @default.
- Q43212287 P2093 Q43212287-A62BFCD6-03C9-40B7-9CEF-DEB020F7B4CB @default.
- Q43212287 P2093 Q43212287-DEE59A89-98C4-478F-9683-47D7FDBFB478 @default.
- Q43212287 P2093 Q43212287-EB538382-4A3F-4B37-ACDB-87F4494A9012 @default.
- Q43212287 P304 Q43212287-1D72A0E3-C125-45D0-8294-2E3DD7271BDA @default.
- Q43212287 P31 Q43212287-6716D69D-59FA-4349-A387-9137C57A18CD @default.
- Q43212287 P356 Q43212287-DCC95EF6-3656-43CB-A8CA-A2F558390501 @default.
- Q43212287 P407 Q43212287-AA035346-BC73-437F-A429-C01A36C22750 @default.
- Q43212287 P433 Q43212287-97FD5945-C6B0-4039-9C30-279DB6482D3F @default.
- Q43212287 P478 Q43212287-CB98CEE1-EAAC-459F-B75E-37A1CA51CF7F @default.
- Q43212287 P50 Q43212287-770A5BE4-7585-4064-82AB-2EEA2FE24EBF @default.
- Q43212287 P50 Q43212287-942D696E-420C-4E72-A2A0-9BD905D206C1 @default.
- Q43212287 P50 Q43212287-DC9F840F-1373-41A1-80F5-7675352A2A47 @default.
- Q43212287 P577 Q43212287-2FE49E4A-4271-4C64-BE82-39EEE89541A4 @default.
- Q43212287 P698 Q43212287-E4B1A230-92EA-46C6-8DB0-4938315A350D @default.
- Q43212287 P921 Q43212287-6351DB6A-A489-4978-98C7-A0BF54D51848 @default.
- Q43212287 P921 Q43212287-80B2CF95-200C-4859-88AB-3458A69977B7 @default.
- Q43212287 P921 Q43212287-8532CF34-BCDF-4B34-B683-EE5FE1288B87 @default.
- Q43212287 P921 Q43212287-AAB1D092-C63E-4A61-BD90-37D35746C9F0 @default.
- Q43212287 P921 Q43212287-C8C56F2E-4A01-4B4A-8014-1EC684432CA2 @default.
- Q43212287 P921 Q43212287-D9D78B7C-F142-4E1B-8E19-692669A6A471 @default.
- Q43212287 P356 JCO.2009.24.0143 @default.
- Q43212287 P698 20026801 @default.
- Q43212287 P1433 Q400292 @default.
- Q43212287 P1476 "Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response" @default.